-
Aimmune Shares Surge 170% As Nestle Set To Acquire Company At $2.6B Enterprise Value
Monday, August 31, 2020 - 3:40am | 320Read More...Nestle S.A. (OTC: NSRGY) subsidiary Nestle Health Sciences (NHSc) is aquiring biopharma company Aimmune Therapeutics, Inc. (Nasdaq: AIMT), under a definitive agreement, the latter announced Monday, sending its stock soaring in the pre-market session. What Happened: NHSc will purchase...
